Hepatitis Panel Testing

Hepatitis Panel Test in Kathmandu — Complete Screening and Accurate Interpretation HAV, HBV and HCV Markers Plus Liver Function Tests

A hepatitis panel combines blood tests for hepatitis A, B and C with liver function markers to give a complete picture of liver health. Learn what each marker means, why interpretation matters, and how Thamel Clinic provides accurate results in Kathmandu.

Medically Reviewed Content

Reviewed by: Thamel Clinic Clinical Team (MBBS, MD)

Last medical review: November 8, 2026

Next scheduled review: May 8, 2027

This content follows evidence-based medical guidelines and is regularly updated to reflect current medical practices.

When to Seek Care Promptly

  • Seek urgent care for jaundice (yellow skin or eyes), severe abdominal pain, or confusion — these may indicate acute liver failure.
  • If you have a positive hepatitis B or C test, do not donate blood or share needles until cleared by a clinician.
  • Pregnant women with positive HBV tests need immediate evaluation to prevent mother-to-child transmission.
  • Do not delay treatment for confirmed hepatitis C — it is curable and earlier treatment prevents liver damage.

Hepatitis Testing in Kathmandu and Nepal

  • High HBV burden — Nepal has a significant hepatitis B burden, particularly in the Terai and among older adults who were not vaccinated as children.
  • HCV emerging — Hepatitis C is increasingly recognized in Nepal, often related to unsafe injections, blood transfusions and dental procedures.
  • Vaccination gaps — Hepatitis B vaccine is available but coverage is incomplete, especially among adults and high-risk groups.
  • Mother-to-child transmission — Without screening, HBV can transmit from mother to child during delivery — a preventable cause of chronic infection.
  • Alcohol-related liver disease — High alcohol consumption in Nepal compounds hepatitis-related liver damage.
  • Affordable testing — Hepatitis panel tests cost Rs. 2,000–5,000 at Thamel Clinic — comparable to routine blood tests.

Overview — What a Hepatitis Panel Tells You

A hepatitis panel is a blood test that screens for infection with the three main hepatitis viruses — hepatitis A (HAV), hepatitis B (HBV) and hepatitis C (HCV) — and assesses liver function. Each virus has different transmission routes, clinical courses and treatments, but all can cause liver inflammation and, if chronic, lead to cirrhosis, liver failure and liver cancer. Testing for all three at once is efficient because they share similar risk factors and the same target organ.

The panel typically includes serological markers for each virus — antibodies and antigens that indicate past exposure, current infection, immunity or vaccination — plus liver function tests such as ALT, AST, bilirubin and albumin. These tests do not just detect infection; they help stage it, distinguish acute from chronic disease, and determine whether treatment or vaccination is needed.

Interpreting hepatitis markers correctly is essential because a positive result does not always mean active infection. For example, a positive hepatitis B surface antibody (anti-HBs) indicates immunity from vaccination or past infection, not disease. A positive hepatitis C antibody means exposure but does not confirm active infection — HCV RNA testing is needed to distinguish resolved from active infection. Without correct interpretation, patients may be unnecessarily treated or falsely reassured.

At Thamel Clinic, we provide comprehensive hepatitis panel testing with expert interpretation. We explain what each marker means in plain language, distinguish infection from immunity, and coordinate appropriate follow-up — including vaccination for susceptible patients, treatment for active infections, and monitoring for chronic disease.

What the Hepatitis Panel Includes

A comprehensive hepatitis panel typically includes serological markers for hepatitis A, B and C, plus liver function tests. For hepatitis A, the panel may include anti-HAV IgM (indicating recent infection) and anti-HAV IgG (indicating past infection or immunity). For hepatitis B, the core markers are HBsAg (surface antigen — indicates current infection), anti-HBs (surface antibody — indicates immunity), and anti-HBc (core antibody — indicates past or current infection).

For hepatitis C, the panel includes anti-HCV antibody (indicating exposure) and, if positive, HCV RNA testing to confirm active infection. Liver function tests — ALT, AST, bilirubin, albumin and sometimes alkaline phosphatase — assess liver damage and help stage disease severity.

Some panels also include hepatitis D testing for patients with HBV, as HDV only infects people with hepatitis B. Additional tests such as HBV DNA (viral load) and HCV genotype may be ordered for patients with confirmed infection to guide treatment decisions.

  • Hepatitis A: anti-HAV IgM (recent) and IgG (immunity).
  • Hepatitis B: HBsAg, anti-HBs, anti-HBc — the core three markers.
  • Hepatitis C: anti-HCV antibody plus HCV RNA if positive.
  • Liver function: ALT, AST, bilirubin, albumin.
  • Hepatitis D testing for HBV-positive patients.
  • HBV DNA and HCV genotype for confirmed infections.

Hepatitis A Markers

Anti-HAV IgM indicates recent infection; IgG indicates past infection or immunity.

Hepatitis B Markers

HBsAg, anti-HBs and anti-HBc together reveal infection status, immunity or vaccination response.

Hepatitis C Testing

Anti-HCV antibody detects exposure; HCV RNA confirms active infection.

Liver Function

ALT, AST, bilirubin and albumin assess liver damage and stage disease.

Interpreting Your Results Correctly

Hepatitis panel interpretation requires understanding that positive results can mean different things. A positive HBsAg means current hepatitis B infection — either acute or chronic. A positive anti-HBs with negative HBsAg means immunity, either from vaccination or past resolved infection. A positive anti-HBc alone may indicate past infection or a false positive — further testing is needed.

For hepatitis C, a positive anti-HCV antibody means you have been exposed to the virus at some point. However, approximately 15–25% of people clear the infection spontaneously without treatment. HCV RNA testing is needed to determine whether you have active infection requiring treatment. A positive antibody with negative RNA means past resolved infection.

Liver function tests add another layer of interpretation. Elevated ALT and AST indicate liver inflammation, which can be caused by hepatitis viruses, alcohol, fatty liver disease, medications or other conditions. Normal liver function tests do not exclude hepatitis infection — many people with chronic HBV or HCV have normal liver enzymes for years before damage becomes apparent.

  • HBsAg positive = current HBV infection (acute or chronic).
  • Anti-HBs positive = immunity from vaccination or past infection.
  • Anti-HCV positive = exposure; HCV RNA needed to confirm active infection.
  • 15–25% of HCV infections resolve spontaneously without treatment.
  • Elevated ALT/AST indicates liver inflammation from various causes.
  • Normal liver enzymes do not exclude hepatitis infection.

HBsAg Positive

Indicates current hepatitis B infection — acute or chronic — requires further evaluation.

Anti-HBs Positive

Indicates immunity from vaccination or past resolved infection — no treatment needed.

Anti-HCV + RNA

Antibody detects exposure; RNA confirms active infection requiring treatment.

Liver Enzymes

ALT/AST elevation indicates inflammation but does not identify the cause.

Who Should Get a Hepatitis Panel?

Hepatitis panel testing is recommended for anyone with risk factors for hepatitis B or C. These include people who inject drugs, men who have sex with men, people with multiple sexual partners, healthcare workers exposed to blood, people who received blood transfusions or organ transplants before screening was routine, and people born in countries with high hepatitis prevalence.

Pregnant women should be screened for hepatitis B at their first antenatal visit because HBV can transmit from mother to child during delivery. Screening for hepatitis C is also recommended for pregnant women with risk factors. All adults should be tested at least once in their lifetime for hepatitis B and C, regardless of perceived risk.

People with symptoms of liver disease — jaundice (yellow skin or eyes), dark urine, pale stools, abdominal pain, nausea, fatigue, or unexplained weight loss — should be tested promptly. However, many people with chronic hepatitis have no symptoms, which is why screening is important even when you feel well.

  • Anyone with risk factors for HBV or HCV infection.
  • People who inject drugs or share needles.
  • Men who have sex with men or people with multiple partners.
  • Healthcare workers exposed to blood or bodily fluids.
  • People born in high-prevalence countries.
  • Pregnant women at first antenatal visit.
  • Anyone with liver disease symptoms (jaundice, dark urine, fatigue).

High-Risk Groups

Injection drug users, MSM, people with multiple partners, healthcare workers.

Pregnancy

HBV screening at first antenatal visit prevents mother-to-child transmission.

Universal Screening

All adults should be tested at least once for HBV and HCV.

Symptomatic Patients

Jaundice, dark urine, abdominal pain or fatigue warrant prompt testing.

Vaccination and Prevention

Vaccines exist for hepatitis A and hepatitis B, but not for hepatitis C. Hepatitis B vaccination is recommended for all infants, children and adults who are not already immune. The vaccine is highly effective — more than 95% of people develop protective antibodies after completing the series. Hepatitis A vaccination is recommended for travelers, people with certain medical conditions, and those at risk of exposure.

If your hepatitis panel shows you are susceptible to HBV (negative for all markers) or HAV (negative for all markers), vaccination is recommended. At Thamel Clinic, we provide hepatitis B and hepatitis A vaccines and can vaccinate you on the same day as your testing if appropriate.

For patients with active HBV or HCV infection, prevention focuses on preventing transmission to others. This includes avoiding sharing needles, practicing safe sex, not donating blood, and informing healthcare providers of your status. Hepatitis C is now curable with direct-acting antiviral medications — a major advance that was not available even a decade ago.

  • Vaccines exist for hepatitis A and B, but not C.
  • HBV vaccine is >95% effective after completing the series.
  • Susceptible patients should be vaccinated.
  • HCV is now curable with direct-acting antivirals.
  • HBV-positive patients need monitoring for liver damage.
  • Avoid sharing needles and practice safe sex to prevent transmission.

Hepatitis B Vaccine

Highly effective vaccine recommended for all susceptible individuals — available at Thamel Clinic.

Hepatitis A Vaccine

Recommended for travelers and high-risk individuals — also available at Thamel Clinic.

No HCV Vaccine

No vaccine exists for hepatitis C, but it is now curable with antiviral medication.

Transmission Prevention

HBV/HCV-positive patients should avoid sharing needles and practice safe sex.

Treatment for Active Infections

Treatment depends on which hepatitis virus is active and the stage of disease. Hepatitis A is typically self-limiting — most people recover fully without specific treatment, though supportive care for symptoms is provided. Hepatitis B treatment depends on viral load, liver enzyme levels and evidence of liver damage; some patients need antiviral therapy while others are monitored.

Hepatitis C is now curable in most cases with direct-acting antiviral (DAA) medications taken for 8–12 weeks. These medications have cure rates exceeding 95% and are generally well tolerated. Treatment decisions depend on HCV genotype, liver fibrosis stage, and other health factors.

For patients with chronic HBV, regular monitoring of viral load, liver enzymes and liver ultrasound is essential to detect progression to cirrhosis or liver cancer. Antiviral therapy is indicated for patients with active disease, elevated viral load, or evidence of liver damage. We coordinate with hepatology specialists for complex cases.

  • HAV is usually self-limiting; supportive care only.
  • HBV treatment depends on viral load and liver damage.
  • HCV is curable with DAA medications — >95% cure rate.
  • Chronic HBV requires regular monitoring for liver damage.
  • Treatment decisions require specialist interpretation.
  • We coordinate with hepatology specialists for complex cases.

Hepatitis A

Usually self-limiting; supportive care for symptoms — no specific antiviral treatment.

Hepatitis B

Treatment depends on viral load and liver damage; some need antivirals, others monitoring.

Hepatitis C

Cured with 8–12 weeks of direct-acting antivirals — >95% success rate.

Monitoring

Chronic HBV requires regular viral load, liver enzyme and ultrasound monitoring.

Cost and Access in Kathmandu

Hepatitis panel testing at Thamel Clinic is affordable. A basic panel (HBV markers plus HCV antibody) costs Rs. 2,000–4,000. A comprehensive panel including hepatitis A markers and liver function tests costs Rs. 3,000–5,000. HCV RNA testing for confirmation costs an additional Rs. 3,000–5,000.

Vaccination costs vary by type. Hepatitis B vaccine typically costs Rs. 1,500–3,000 per dose, and a complete series requires 3 doses over 6 months. Hepatitis A vaccine costs approximately Rs. 3,000–5,000 per dose. We provide transparent pricing and can discuss payment options for patients who need vaccination.

For patients with confirmed hepatitis B or C infection, treatment costs vary widely. HBV antiviral therapy can cost Rs. 5,000–15,000 per month depending on the medication. HCV treatment with DAA medications can cost Rs. 50,000–200,000 for a full course, though generic versions are becoming available at lower cost. We help patients understand costs and access options.

  • Basic panel costs Rs. 2,000–4,000.
  • Comprehensive panel costs Rs. 3,000–5,000.
  • HCV RNA confirmation costs Rs. 3,000–5,000.
  • HBV vaccine costs Rs. 1,500–3,000 per dose (3 doses needed).
  • HAV vaccine costs Rs. 3,000–5,000 per dose.
  • HCV treatment costs Rs. 50,000–200,000 for full course.

Affordable Testing

Hepatitis panel testing costs Rs. 2,000–5,000 — comparable to routine blood tests.

Vaccination Costs

HBV vaccine Rs. 1,500–3,000 per dose; HAV vaccine Rs. 3,000–5,000 per dose.

Treatment Costs

HBV antivirals Rs. 5,000–15,000 monthly; HCV cure Rs. 50,000–200,000 per course.

Transparent Pricing

Itemized costs provided before any test, vaccine or treatment is performed.

Hepatitis Panel Testing and Related Services — Indicative Costs

ServiceWhat It IncludesCost (NPR)
Initial consultationPrivate assessment and hepatitis risk discussionRs. 450
Basic hepatitis panelHBV markers (HBsAg, anti-HBs, anti-HBc) plus HCV antibodyRs. 2,000–4,000
Comprehensive hepatitis panelHAV markers plus HBV markers plus HCV antibody plus liver functionRs. 3,000–5,000
HCV RNA testConfirms active hepatitis C infection if antibody positiveRs. 3,000–5,000
HBV DNA (viral load)Measures hepatitis B viral load for treatment decisionsRs. 4,000–8,000
Hepatitis B vaccinePer dose — 3 doses required over 6 monthsRs. 1,500–3,000
Hepatitis A vaccinePer dose — single dose usually sufficientRs. 3,000–5,000
Liver function testsALT, AST, bilirubin, albumin — included in comprehensive panelIncluded

Prices are in Nepali Rupees and are indicative; confirm current rates when booking.

Why Patients Choose Thamel Clinic for Hepatitis Panel Testing

  • Complete panel — HAV, HBV and HCV markers plus liver function tests in one visit.
  • Expert interpretation — We explain what each marker means and distinguish infection from immunity.
  • Correct follow-up — Vaccination for susceptible patients, treatment for active infections, monitoring for chronic disease.
  • Pregnancy expertise — HBV screening at first antenatal visit to prevent mother-to-child transmission.
  • Vaccination available — Hepatitis A and B vaccines provided on-site for eligible patients.
  • Specialist coordination — We refer to hepatology specialists for complex cases.
  • Confidential care — Private consultations in central Kathmandu with non-judgmental staff.
  • Affordable pricing — Transparent itemized costs; testing comparable to routine blood tests.

Relevant Specialist Expertise

These clinicians provide care within their scope of practice at our clinic.

Portrait of Dr. Sushil Sitaula, Consultant in Internal Medicine

Dr. Sushil Sitaula

Consultant in Internal Medicine

MBBS
MD — Internal Medicine

Nepal Medical Council Registration No. 6973

Dr. Sushil Sitaula is a Consultant in Internal Medicine with a special interest in sexual health. He holds an MBBS and an MD in Internal Medicine and is registered with the Nepal Medical Council (Registration No. 6973).

Key Expertise

General Internal MedicineSexual HealthSexual HealthGeneral Internal Medicine

Frequently Asked Questions

What does a hepatitis panel test for?

A hepatitis panel tests for hepatitis A, B and C using blood tests that detect antibodies and antigens. It also includes liver function tests (ALT, AST, bilirubin, albumin) to assess liver health. Some panels include hepatitis D testing for HBV-positive patients.

Do I need all three hepatitis tests?

If you have risk factors or are being screened for the first time, yes — testing for all three is efficient because they share risk factors and the same target organ. If you have been vaccinated for HBV, you may only need HCV testing.

What does a positive hepatitis B test mean?

It depends on which marker is positive. HBsAg positive means current infection. Anti-HBs positive means immunity from vaccination or past infection. Anti-HBc positive alone may indicate past infection. We will explain your specific results clearly.

Can hepatitis C be cured?

Yes. Hepatitis C is now curable in most cases with direct-acting antiviral medications taken for 8–12 weeks. Cure rates exceed 95%. However, you need HCV RNA testing to confirm active infection before treatment.

Should I be vaccinated for hepatitis?

If your panel shows you are susceptible to HBV or HAV, vaccination is recommended. Hepatitis B vaccine is >95% effective and recommended for all susceptible individuals. Hepatitis A vaccine is recommended for travelers and high-risk groups.

I feel fine. Do I still need hepatitis testing?

Yes. Many people with chronic hepatitis B or C have no symptoms for years before liver damage becomes apparent. Screening is the only way to detect silent infection. All adults should be tested at least once.

Is hepatitis testing confidential?

Yes. All testing and results at Thamel Clinic are handled privately and discreetly. Your results are not shared with anyone without your consent.

How much does a hepatitis panel cost?

A basic panel costs Rs. 2,000–4,000. A comprehensive panel costs Rs. 3,000–5,000. HCV RNA confirmation costs Rs. 3,000–5,000. Vaccines cost Rs. 1,500–5,000 per dose depending on type.

What happens if I test positive for hepatitis?

We will explain your results, determine whether you have active infection or immunity, and discuss next steps. For active HBV or HCV, we coordinate treatment or refer to specialists. For susceptible patients, we recommend vaccination.

Can hepatitis be spread through sex?

Hepatitis B can be spread through sexual contact. Hepatitis C can also be transmitted sexually, though less efficiently than through blood. Hepatitis A is spread through contaminated food and water, not typically through sex. Safe sex practices reduce HBV/HCV transmission risk.

Still have questions? Contact us or book an appointment for personalized guidance.

Related Services & Guides

Related Health Guides

Medical Review & Sources

Medically reviewed by: Thamel Clinic Clinical Team (MBBS, MD)

Role: Sexual health and STD clinical reviewers, Thamel Clinic, Kathmandu

Last reviewed: 2026-11-08

Reviewed against current WHO and CDC guidance. This is general medical information; a registered clinician must assess each patient before treatment.

View clinic team and credentials

References

  1. Hepatitis B fact sheet — World Health Organization, 2023
  2. Hepatitis C fact sheet — World Health Organization, 2023
  3. Hepatitis A fact sheet — World Health Organization, 2023
  4. Hepatitis guidance — Centers for Disease Control and Prevention, 2024

Medical information is general guidance only and does not replace an individual consultation. Treatment decisions are made after clinical assessment, including allergy and pregnancy review.

Medical Disclaimer

Important information about using this medical website

Educational Purpose Only

The information provided on this website, including all text, graphics, images, and other material, is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

No Doctor-Patient Relationship

Use of this website does not create a doctor-patient relationship. The information provided is not tailored to your specific medical condition or health needs. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Emergency Situations

If you think you may have a medical emergency, call your doctor or emergency services immediately. In Nepal, call 102 for emergency services or go to the nearest hospital emergency room.

Emergency Contact Information:

National Emergency:

102 (Ambulance)

Our Clinic:

+977-9700682800 (WhatsApp available 24/7)

Bir Hospital Emergency:

+977-1-4412400

TU Teaching Hospital:

+977-1-4434320

Timeliness of Information

Medical information changes rapidly. While we strive to provide current and accurate information, we make no guarantees about the completeness, accuracy, reliability, suitability, or availability with respect to the website or the information contained on the website.

Professional Medical Advice Required

Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you have any specific questions about any medical matter, you should consult your doctor or other professional healthcare provider.

Treatment and Diagnosis

Do not use the information on this website to diagnose or treat any health problem or disease. The descriptions of treatments and medications provided are for general informational purposes only and do not constitute medical advice.

Limitation of Liability

In no event shall we be liable for any loss or damage arising from the use of this website or reliance on the information provided herein. This includes, but is not limited to, direct, indirect, incidental, punitive, and consequential damages.

Nepal-Specific Considerations

This website is operated in Nepal and is intended for users in Nepal. The medical information provided may not be applicable to healthcare systems outside Nepal. Always consult with local healthcare providers familiar with Nepal's healthcare system and regulations.

Last Updated: November 20, 2026 |Clinic: Thamel Clinic |Licensed: Registered

WhatsAppBook Now